Tigermed board to meet for third quarter report approval

Hangzhou Tigermed Consulting Co., Ltd. announced its board of directors will hold a meeting on Tuesday, October 28, 2025. The primary purpose of this meeting is to consider and approve the company's third quarterly report, which covers the nine months ending September 30, 2025. Additionally, the board will address any other relevant resolutions that may arise.

The announcement was made in Hong Kong on October 16, 2025. The company operates under the stock code 3347.

As of the announcement date, the executive directors include Dr. Ye Xiaoping, Ms. Cao Xiaochun, Mr. Wu Hao, and Mr. Wen Zengyu. The independent non-executive directors are Mr. Liu Kai Yu Kenneth, Mr. Yuan Huagang, and Ms. Liu Yuwen. The board's order was given by Ye Xiaoping, chairman of Hangzhou Tigermed Consulting Co., Ltd.